<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <updateDate>2015-01-22T05:00:00Z</updateDate>
          <text><![CDATA[<p><b>Ensuring Patient Access and Effective Drug Enforcement Act of 2015</b></p> <p> Amends the Controlled Substances Act to define: (1) "factors as may be relevant to and consistent with the public health and safety," for purposes of the Attorney General's determination of whether registering an applicant to manufacture or distribute a controlled substance in schedule I or II is in the public interest, as factors that are relevant to and consistent with the findings of such Act; and (2) "imminent danger to the public health or safety," for purposes of the suspension of such a registration, to mean that in the absence of an immediate suspension order, controlled substances will continue to be intentionally diverted outside of legitimate distribution channels or distributed or dispensed outside the usual course of professional practices or in a manner that poses a present or foreseeable risk of serious adverse health consequences or death.</p> <p>Requires an order to show cause as to why such a registration should not be denied, revoked, or suspended to: (1) contain a statement of the basis for the denial, revocation, or suspension, including specific citations to any laws or regulations alleged to be violated; (2) direct the applicant or registrant to appear before the Attorney General at a specific place and time within 30 days after receipt of the order; and (3) notify the applicant or registrant of the opportunity to submit a corrective action plan on or before such appearance. Requires the Attorney General, upon review of any such plan, to determine whether denial, revocation, or suspension proceedings should be discontinued or deferred for purposes of modifications to such plan. Makes such requirements inapplicable to the issuance of an immediate suspension order.</p> <p>Directs the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs and the Director of the Centers for Disease Control and Prevention, to submit a report identifying: (1) obstacles to legitimate patient access to controlled substances; (2) issues with diversion of controlled substances; and (3) how collaboration between federal, state, local, and tribal law enforcement agencies and the pharmaceutical industry can benefit patients and prevent diversion and abuse of controlled substances.</p>]]></text>
          <name>Introduced in House</name>
          <lastSummaryUpdateDate>2015-02-09T20:20:08Z</lastSummaryUpdateDate>
          <actionDesc>Introduced in House</actionDesc>
          <actionDate>2015-01-22</actionDate>
        </item>
        <item>
          <versionCode>28</versionCode>
          <updateDate>2015-04-20T13:41:21Z</updateDate>
          <text><![CDATA[<p>(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)</p> <p><b>Ensuring Patient Access and Effective Drug Enforcement Act of 2015</b></p> <p> (Sec. 2) Amends the Controlled Substances Act to define: (1) "factors as may be relevant to and consistent with the public health and safety," for purposes of the Attorney General's determination of whether registering an applicant to manufacture or distribute a controlled substance in schedule I or II is in the public interest, as factors that are relevant to and consistent with the findings of such Act; and (2) "imminent danger to the public health or safety," for purposes of the suspension of such a registration, to mean that in the absence of an immediate suspension order, controlled substances will continue to be intentionally diverted outside of legitimate distribution channels or distributed or dispensed outside the usual course of professional practices or in a manner that poses a present or foreseeable risk of serious adverse health consequences or death.</p> <p>Requires an order to show cause as to why such a registration should not be denied, revoked, or suspended to: (1) contain a statement of the basis for the denial, revocation, or suspension, including specific citations to any laws or regulations alleged to be violated; (2) direct the applicant or registrant to appear before the Attorney General at a specific place and time within 30 days after receipt of the order; and (3) notify the applicant or registrant of the opportunity to submit a corrective action plan on or before such appearance. Requires the Attorney General, upon review of any such plan, to determine whether denial, revocation, or suspension proceedings should be discontinued or deferred for purposes of modifications to such plan. Makes such requirements inapplicable to the issuance of an immediate suspension order.</p> <p>(Sec. 3) Directs the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs and the Director of the Centers for Disease Control and Prevention, to submit a report identifying: (1) obstacles to legitimate patient access to controlled substances; (2) issues with diversion of controlled substances; and (3) how collaboration between federal, state, local, and tribal law enforcement agencies and the pharmaceutical industry can benefit patients and prevent diversion and abuse of controlled substances.</p>]]></text>
          <name>Reported to House without amendment, Part I</name>
          <lastSummaryUpdateDate>2015-05-20T19:46:15Z</lastSummaryUpdateDate>
          <actionDesc>Reported to House without amendment, Part I</actionDesc>
          <actionDate>2015-04-20</actionDate>
        </item>
        <item>
          <versionCode>36</versionCode>
          <updateDate>2015-04-21T11:48:49Z</updateDate>
          <text><![CDATA[<p><b>Ensuring Patient Access and Effective Drug Enforcement Act of 2015</b></p> <p> (Sec. 2) Amends the Controlled Substances Act to define: (1) "factors as may be relevant to and consistent with the public health and safety," for purposes of the Attorney General's determination of whether registering an applicant to manufacture or distribute a controlled substance in schedule I or II is in the public interest, as factors that are relevant to and consistent with the findings of such Act; and (2) "imminent danger to the public health or safety," for purposes of the suspension of such a registration, to mean that in the absence of an immediate suspension order, controlled substances will continue to be distributed or dispensed by a registrant who knows or should know through fulfilling the obligations of the registrant under this Act that the dispensing is outside the usual course of professional practice, the distribution or dispensing poses a present or foreseeable risk of adverse health consequences or death due to the abuse or misuse of the controlled substances, or the controlled substances will continue to be diverted outside of legitimate distribution channels.</p> <p>Requires an order to show cause as to why such a registration should not be denied, revoked, or suspended to: (1) contain a statement of the basis for the denial, revocation, or suspension, including specific citations to any laws or regulations alleged to be violated; (2) direct the applicant or registrant to appear before the Attorney General at a specific place and time within 30 days after receipt of the order; and (3) notify the applicant or registrant of the opportunity to submit a corrective action plan on or before such appearance. Requires the Attorney General, upon review of any such plan, to determine whether denial, revocation, or suspension proceedings should be discontinued or deferred for purposes of modifications to such plan. Makes such requirements inapplicable to the issuance of an immediate suspension order.</p> <p>(Sec. 3) Directs the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs and the Director of the Centers for Disease Control and Prevention, to submit a report identifying: (1) obstacles to legitimate patient access to controlled substances; (2) issues with diversion of controlled substances; and (3) how collaboration between federal, state, local, and tribal law enforcement agencies and the pharmaceutical industry can benefit patients and prevent diversion and abuse of controlled substances.</p>]]></text>
          <name>Passed House amended</name>
          <lastSummaryUpdateDate>2015-07-09T20:53:00Z</lastSummaryUpdateDate>
          <actionDesc>Passed House amended</actionDesc>
          <actionDate>2015-04-21</actionDate>
        </item>
      </billSummaries>
    </summaries>
    <title>Ensuring Patient Access and Effective Drug Enforcement Act of 2015</title>
    <originChamber>House</originChamber>
    <cboCostEstimates>
      <item>
        <title>H.R. 471, Ensuring Patient Access and Effective Drug Enforcement Act of 2015</title>
        <pubDate>2015-03-02T19:49:07Z</pubDate>
        <url>https://www.cbo.gov/publication/49971</url>
      </item>
    </cboCostEstimates>
    <cosponsors>
      <item>
        <fullName>Rep. Welch, Peter [D-VT-At Large]</fullName>
        <party>D</party>
        <sponsorshipDate>2015-01-22</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <lastName>Welch</lastName>
        <district>0</district>
        <identifiers>
          <lisID>1879</lisID>
          <gpoId>8204</gpoId>
          <bioguideId>W000800</bioguideId>
        </identifiers>
        <state>VT</state>
        <firstName>Peter</firstName>
        <bioguideId>W000800</bioguideId>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <middleName />
      </item>
      <item>
        <fullName>Rep. Blackburn, Marsha [R-TN-7]</fullName>
        <party>R</party>
        <sponsorshipDate>2015-01-22</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <lastName>Blackburn</lastName>
        <district>7</district>
        <identifiers>
          <bioguideId>B001243</bioguideId>
          <gpoId>8154</gpoId>
          <lisID>1748</lisID>
        </identifiers>
        <state>TN</state>
        <firstName>Marsha</firstName>
        <bioguideId>B001243</bioguideId>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <middleName />
      </item>
      <item>
        <fullName>Rep. Chu, Judy [D-CA-27]</fullName>
        <party>D</party>
        <sponsorshipDate>2015-01-22</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <lastName>Chu</lastName>
        <district>27</district>
        <identifiers>
          <gpoId>7837</gpoId>
          <bioguideId>C001080</bioguideId>
          <lisID>1970</lisID>
        </identifiers>
        <state>CA</state>
        <firstName>Judy</firstName>
        <bioguideId>C001080</bioguideId>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <middleName />
      </item>
      <item>
        <fullName>Rep. Collins, Doug [R-GA-9]</fullName>
        <party>R</party>
        <sponsorshipDate>2015-02-11</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <lastName>Collins</lastName>
        <district>9</district>
        <identifiers>
          <lisID>2121</lisID>
          <gpoId />
          <bioguideId>C001093</bioguideId>
        </identifiers>
        <state>GA</state>
        <firstName>Doug</firstName>
        <bioguideId>C001093</bioguideId>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <middleName />
      </item>
      <item>
        <fullName>Rep. Bilirakis, Gus M. [R-FL-12]</fullName>
        <party>R</party>
        <sponsorshipDate>2015-02-11</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <lastName>Bilirakis</lastName>
        <district>12</district>
        <identifiers>
          <lisID>1838</lisID>
          <gpoId>7881</gpoId>
          <bioguideId>B001257</bioguideId>
        </identifiers>
        <state>FL</state>
        <firstName>Gus</firstName>
        <bioguideId>B001257</bioguideId>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <middleName>M.</middleName>
      </item>
      <item>
        <fullName>Rep. Costello, Ryan A. [R-PA-6]</fullName>
        <party>R</party>
        <sponsorshipDate>2015-03-25</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <lastName>Costello</lastName>
        <district>6</district>
        <identifiers>
          <lisID>2266</lisID>
          <gpoId />
          <bioguideId>C001106</bioguideId>
        </identifiers>
        <state>PA</state>
        <firstName>Ryan</firstName>
        <bioguideId>C001106</bioguideId>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <middleName>A.</middleName>
      </item>
    </cosponsors>
    <createDate>2015-01-23T04:46:26Z</createDate>
    <relatedBills>
      <item>
        <congress>114</congress>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
          <item>
            <identifiedBy>House</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <type>S</type>
        <latestTitle>Ensuring Patient Access and Effective Drug Enforcement Act of 2016</latestTitle>
        <number>483</number>
        <latestAction>
          <text>Became Public Law No: 114-145.</text>
          <actionDate>2016-04-19</actionDate>
        </latestAction>
      </item>
    </relatedBills>
    <congress>114</congress>
    <version>1.0.0</version>
    <sponsors>
      <item>
        <fullName>Rep. Marino, Tom [R-PA-10]</fullName>
        <firstName>Tom</firstName>
        <party>R</party>
        <identifiers>
          <lisID>2053</lisID>
          <gpoId>8128</gpoId>
          <bioguideId>M001179</bioguideId>
        </identifiers>
        <lastName>Marino</lastName>
        <bioguideId>M001179</bioguideId>
        <byRequestType />
        <district>10</district>
        <state>PA</state>
        <middleName />
      </item>
    </sponsors>
    <billType>HR</billType>
    <actions>
      <item>
        <actionDate>2015-04-22</actionDate>
        <committee>
          <name>Judiciary Committee</name>
          <systemCode>ssju00</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Received in the Senate and Read twice and referred to the Committee on the Judiciary.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <type>Floor</type>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <actionCode>H38310</actionCode>
        <links />
        <actionTime>16:17:07</actionTime>
        <actionDate>2015-04-21</actionDate>
        <committee />
      </item>
      <item>
        <type>Floor</type>
        <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2329)</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <actionCode>H37300</actionCode>
        <links>
          <link>
            <name>H2329</name>
            <url>https://www.congress.gov/congressional-record/volume-161/house-section/page/H2329</url>
          </link>
        </links>
        <actionTime>16:17:04</actionTime>
        <actionDate>2015-04-21</actionDate>
        <committee />
      </item>
      <item>
        <type>Floor</type>
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2329)</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <actionCode>8000</actionCode>
        <links>
          <link>
            <name>H2329</name>
            <url>http://tntwxavlp01.loc.gov/congressional-record/volume-161/house-section/page/H2329</url>
          </link>
        </links>
        <actionTime>16:17:04</actionTime>
        <actionDate>2015-04-21</actionDate>
        <committee />
      </item>
      <item>
        <type>Floor</type>
        <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 471.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <actionCode>H8D000</actionCode>
        <links>
          <link>
            <name>H.R. 471</name>
            <url>https://www.congress.gov/bill/114th-congress/house-bill/471</url>
          </link>
        </links>
        <actionTime>15:56:10</actionTime>
        <actionDate>2015-04-21</actionDate>
        <committee />
      </item>
      <item>
        <type>Floor</type>
        <text>Considered under suspension of the rules. (consideration: CR H2329-2332)</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <actionCode>H30000</actionCode>
        <links>
          <link>
            <name>H2329-2332</name>
            <url>https://www.congress.gov/congressional-record/volume-161/house-section/page/H2329-2332</url>
          </link>
        </links>
        <actionTime>15:56:08</actionTime>
        <actionDate>2015-04-21</actionDate>
        <committee />
      </item>
      <item>
        <type>Floor</type>
        <text>Mrs. Blackburn moved to suspend the rules and pass the bill, as amended.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <actionCode>H30300</actionCode>
        <links />
        <actionTime>15:56:03</actionTime>
        <actionDate>2015-04-21</actionDate>
        <committee />
      </item>
      <item>
        <type>Calendars</type>
        <text>Placed on the Union Calendar, Calendar No. 63.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <actionCode>H12410</actionCode>
        <links />
        <actionDate>2015-04-20</actionDate>
        <committee />
      </item>
      <item>
        <type>Discharge</type>
        <text>Committee on the Judiciary discharged.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <actionCode>H12300</actionCode>
        <links />
        <actionDate>2015-04-20</actionDate>
        <committee>
          <name>Judiciary Committee</name>
          <systemCode>hsju00</systemCode>
        </committee>
      </item>
      <item>
        <type>Committee</type>
        <text>Committee on the Judiciary discharged.</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <actionCode>5500</actionCode>
        <links />
        <actionDate>2015-04-20</actionDate>
        <committee>
          <name>Judiciary Committee</name>
          <systemCode>hsju00</systemCode>
        </committee>
      </item>
      <item>
        <type>Committee</type>
        <text>Reported by the Committee on Energy and Commerce. H. Rept. 114-85, Part I.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <actionCode>H12200</actionCode>
        <links>
          <link>
            <name>H. Rept. 114-85</name>
            <url>https://www.congress.gov/congressional-report/114th-congress/house-report/85</url>
          </link>
        </links>
        <actionDate>2015-04-20</actionDate>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
      </item>
      <item>
        <type>Committee</type>
        <text>Reported by the Committee on Energy and Commerce. H. Rept. 114-85, Part I.</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <actionCode>5000</actionCode>
        <links>
          <link>
            <name>H. Rept. 114-85</name>
            <url>http://tntwxavlp01.loc.gov/congressional-report/114th-congress/house-report/85</url>
          </link>
        </links>
        <actionDate>2015-04-20</actionDate>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
      </item>
      <item>
        <actionDate>2015-02-19</actionDate>
        <committee>
          <name>Crime, Terrorism, Homeland Security, and Investigations Subcommittee</name>
          <systemCode>hsju08</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2015-01-23</actionDate>
        <committee>
          <name>Health Subcommittee</name>
          <systemCode>hsif14</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <type>IntroReferral</type>
        <text>Referred to House Judiciary</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <actionCode>H11100</actionCode>
        <links />
        <actionDate>2015-01-22</actionDate>
        <committee>
          <name>Judiciary Committee</name>
          <systemCode>hsju00</systemCode>
        </committee>
      </item>
      <item>
        <type>IntroReferral</type>
        <text>Referred to House Energy and Commerce</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <actionCode>H11100</actionCode>
        <links />
        <actionDate>2015-01-22</actionDate>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
      </item>
      <item>
        <type>IntroReferral</type>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <actionCode>H11100-A</actionCode>
        <links />
        <actionDate>2015-01-22</actionDate>
        <committee />
      </item>
      <item>
        <type>IntroReferral</type>
        <text>Introduced in House</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <actionCode>Intro-H</actionCode>
        <links />
        <actionDate>2015-01-22</actionDate>
        <committee />
      </item>
      <item>
        <type>IntroReferral</type>
        <text>Introduced in House</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <actionCode>1000</actionCode>
        <links />
        <actionDate>2015-01-22</actionDate>
        <committee />
      </item>
      <actionByCounts>
        <senate>1</senate>
        <houseOfRepresentatives>18</houseOfRepresentatives>
      </actionByCounts>
      <actionTypeCounts>
        <committeeReportOfABill>1</committeeReportOfABill>
        <billReferralsAggregate>1</billReferralsAggregate>
        <referredToCommittee>1</referredToCommittee>
        <motionMadeToSuspendTheRules>1</motionMadeToSuspendTheRules>
        <committeeDischarged>1</committeeDischarged>
        <houseCommitteeDischarged>1</houseCommitteeDischarged>
        <reportedToHouse>1</reportedToHouse>
        <passedAgreedToInHouse>1</passedAgreedToInHouse>
        <billReferrals>2</billReferrals>
        <finalPassageUnderSuspensionOfTheRulesResults>1</finalPassageUnderSuspensionOfTheRulesResults>
        <considerationByHouse>1</considerationByHouse>
        <introducedInTheHouse>1</introducedInTheHouse>
        <motionToReconsiderResults>1</motionToReconsiderResults>
        <introducedInHouse>1</introducedInHouse>
        <placeholderTextForH>2</placeholderTextForH>
        <generalDebate>1</generalDebate>
        <unionCalendarAssignment>1</unionCalendarAssignment>
      </actionTypeCounts>
    </actions>
    <amendments />
    <policyArea>
      <name>Crime and Law Enforcement</name>
    </policyArea>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Administrative remedies</name>
          </item>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Department of Justice</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Government information and archives</name>
          </item>
          <item>
            <name>Government studies and investigations</name>
          </item>
          <item>
            <name>Health care coverage and access</name>
          </item>
          <item>
            <name>Licensing and registrations</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
          <item>
            <name>Retail and wholesale trades</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Crime and Law Enforcement</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <introducedDate>2015-01-22</introducedDate>
    <laws />
    <notes />
    <committees>
      <billCommittees>
        <item>
          <systemCode>ssju00</systemCode>
          <type>Standing</type>
          <subcommittees />
          <name>Judiciary Committee</name>
          <chamber>Senate</chamber>
          <activities>
            <item>
              <date>2015-04-22T16:02:01Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
        <item>
          <systemCode>hsju00</systemCode>
          <type>Standing</type>
          <subcommittees>
            <item>
              <name>Crime, Terrorism, Homeland Security, and Investigations Subcommittee</name>
              <systemCode>hsju08</systemCode>
              <activities>
                <item>
                  <date>2015-02-19T14:14:44Z</date>
                  <name>Referred to</name>
                </item>
              </activities>
            </item>
          </subcommittees>
          <name>Judiciary Committee</name>
          <chamber>House</chamber>
          <activities>
            <item>
              <date>2015-04-20T18:21:25Z</date>
              <name>Discharged from</name>
            </item>
            <item>
              <date>2015-01-22T14:01:10Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
        <item>
          <systemCode>hsif00</systemCode>
          <type>Standing</type>
          <subcommittees>
            <item>
              <name>Health Subcommittee</name>
              <systemCode>hsif14</systemCode>
              <activities>
                <item>
                  <date>2015-01-23T18:18:28Z</date>
                  <name>Referred to</name>
                </item>
              </activities>
            </item>
          </subcommittees>
          <name>Energy and Commerce Committee</name>
          <chamber>House</chamber>
          <activities>
            <item>
              <date>2015-04-20T18:21:03Z</date>
              <name>Reported by</name>
            </item>
            <item>
              <date>2015-01-22T14:01:05Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>H. Rept. 114-85</citation>
      </committeeReport>
    </committeeReports>
    <latestAction>
      <actionDate>2015-04-22</actionDate>
      <links />
      <text>Received in the Senate and Read twice and referred to the Committee on the Judiciary.</text>
    </latestAction>
    <constitutionalAuthorityStatementText><![CDATA[<pre>From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. MARINO:H.R. 471.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3 of the United StatesConstitution. The Constitution's Commerce Clause allowsCongress to enact laws when reasonably related to theregulation of interstate commerce.[Page H533]</pre>]]></constitutionalAuthorityStatementText>
    <billNumber>471</billNumber>
    <calendarNumbers>
      <item>
        <calendar>U00063</calendar>
        <number />
      </item>
    </calendarNumbers>
    <updateDate>2017-06-02T19:54:09Z</updateDate>
    <titles>
      <item>
        <titleType>Short Titles as Passed House</titleType>
        <title>Ensuring Patient Access and Effective Drug Enforcement Act of 2015</title>
        <chamberCode>H</chamberCode>
        <parentTitleType>Short Titles House of Representatives</parentTitleType>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Reported to House</titleType>
        <title>Ensuring Patient Access and Effective Drug Enforcement Act of 2015</title>
        <chamberCode>H</chamberCode>
        <parentTitleType>Short Titles House of Representatives</parentTitleType>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Ensuring Patient Access and Effective Drug Enforcement Act of 2015</title>
        <chamberCode />
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To improve enforcement efforts related to prescription drug diversion and abuse, and for other purposes.</title>
        <chamberCode />
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <titleType>Display Title</titleType>
        <title>Ensuring Patient Access and Effective Drug Enforcement Act of 2015</title>
        <chamberCode />
        <parentTitleType />
        <chamberName />
      </item>
    </titles>
    <recordedVotes />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

